Looking to publish in Journal of Molecular Medicine? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowThe Journal of Molecular Medicine focuses on basic findings from disease pathogenesis to therapy research across all human diseases. Studies based on model organisms are considered if relevant to human disease, while studies solely based on cell lines will not be considered. The journal continues the Berliner Klinische Wochenschrift (1864). Authors may publish through the traditional route or immediate gold Open Access.
Looking to publish in Journal of Molecular Medicine? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Journal of Molecular Medicine accepts the following article types. Click on an article type to view submission instructions.
Original Articles
Review Articles
Commentaries
Editorials
Recent Publications
High mobility group motif proteins’ role in fibrosis, inflammation, and vascular injury in systemic sclerosis
Fabian A. Mendoza, Sonsoles Piera-Velazquez, Sergio A Jimenez
Correction to: a novel tsRNA, tRF-33-6978WPRLXN4V0O inhibits breast cancer development via regulating PTEN/AKT pathway in BHLHA15 mediated manner
Ji Dai, Haoqiang Ji, Huihui Bai, Qilong Zhong, Haohang Sun, Mengze Chen, Qi Chen, Meidi Yan, Dandan Zhang, Shuangshuang Zhang
SIRT1 regulates CaOx crystal-induced exacerbation of renal mitochondrial dysfunction and fibrosis through PPAR-α in aged mice
Yuexian Xu, Kaiguo Xia, Xike Mao, Junfeng Yao, Bingbing Hou, Wei Wang, Zongyao Hao
Vasoactive intestinal peptide advances chondrogenesis and modulates pathogenic mediators in human osteoarthritis
Karolina Tecza, Cristina Rodríguez-Hernández, Raúl Villanueva-Romero, David Castro-Vázquez, Alicia Cabrera-Martín, Paula Arribas-Castaño, Mar Carrión, Irene Gutiérrez-Cañas, Raquel Largo, Valentina Calamia, Francisco J. Blanco, Rosa P. Gomariz, Yasmina Juarranz, Carmen Martínez, Selene Pérez-García
MEK inhibitor cobimetinib increases calreticulin and induces immune modulation in TNBC
Ling-Ming Tseng, Ka-Yi Lau, Ji-Lin Chen, Pei-Yi Chu, Chun-Teng Huang, Wan-Lun Wang, Yuan-Ya Chang, Jiun-I Lai, Chi-Cheng Huang, Ming-Shen Dai, Chun-Yu Liu
Frequently asked questions
How long does it take to publish?
Submission to first decision (median): 17 days.
Reformat to Journal of Molecular Medicine using Livewrite PremiumIs a cover letter required?
A submission letter is referenced for reviewer suggestions when an institutional email address is unavailable, and the corresponding author should mention unpublished material in a cover letter to the Editor.
Reformat to Journal of Molecular Medicine using Livewrite PremiumWhat are the publication costs?
No publication charges except for special services; immediate gold Open Access publication charges incur.
Reformat to Journal of Molecular Medicine using Livewrite Premium